Key Events This Week
4 May: Week opens at Rs.978.75
6 May: Hits lower circuit amid heavy selling pressure
7 May: Strong rebound with 4.91% gain
8 May: Hits upper circuit, closing at Rs.1,006.60
4 May 2026: Week Opens Steady at Rs.978.75
The stock began the week at Rs.978.75 on 4 May 2026, with a moderate trading volume of 5,379 shares. The Sensex closed at 35,741.67, setting a neutral backdrop for the stock’s initial session. No significant news impacted the price on this day, allowing Venus Remedies to start the week on a stable footing.
6 May 2026: Venus Remedies Hits Lower Circuit Amid Heavy Selling Pressure
On 6 May, Venus Remedies faced intense selling pressure, triggering its lower circuit limit. The stock closed sharply lower at Rs.924.50, down 2.43% from the previous day’s close of Rs.947.55, with an intraday low touching Rs.902.45. This represented a maximum daily loss of 3.87% intraday, signalling a strong bearish momentum. The total traded volume was 22,551 shares, generating a turnover of approximately ₹2.07 crore.
This decline contrasted with the Sensex’s robust gain of 1.40% that day, closing at 36,211.89, and the Pharmaceuticals & Biotechnology sector’s 1.30% rise, highlighting company-specific challenges. Delivery volumes fell sharply by 59.12% compared to the five-day average, indicating waning investor participation and possible exit by long-term holders. Despite this short-term weakness, the stock remained above its longer-term moving averages, suggesting the correction was technical rather than structural.
Perfect timing to enter! This Small Cap from IT - Software just turned profitable with growth momentum clearly building up. Get in before the broader market notices!
- - New profitability achieved
- - Growth momentum building
- - Under-the-radar entry
7 May 2026: Strong Rebound with 4.91% Gain
Following the lower circuit hit, Venus Remedies staged a notable recovery on 7 May, closing at Rs.969.90, up 4.91% from the previous close of Rs.924.50. The stock outperformed the Sensex, which rose 0.34% to 36,333.79. The rebound was supported by moderate volume of 1,246 shares, reflecting renewed buying interest. This sharp bounce back helped the stock regain some lost ground and indicated that the prior day’s decline may have been an overreaction.
8 May 2026: Upper Circuit Hit Amid Strong Buying Momentum
On the final trading day of the week, Venus Remedies surged to its upper circuit limit, closing at Rs.1,006.60, a 3.78% gain over the previous day’s close. The stock’s intraday high reached Rs.1,016.15, exactly the 5% upper price band limit. This strong buying momentum was accompanied by a significant increase in volume to 17,347 shares, generating turnover of ₹4.39 crore.
Despite the Sensex declining 0.40% to 36,187.29 and the Pharmaceuticals & Biotechnology sector gaining only 0.32%, Venus Remedies demonstrated relative strength. However, delivery volumes declined by 22.62% compared to the five-day average, suggesting that much of the buying interest was speculative or intraday rather than long-term accumulation. The stock’s technical position improved, trading above all key moving averages, signalling a robust bullish trend.
Thinking about Venus Remedies Ltd? Our real-time Verdict report breaks down everything – from financial health and peer comparison to technical signals and fair valuation for this micro-cap stock!
- - Real-time Verdict available
- - Financial health breakdown
- - Fair valuation calculated
Daily Price Performance: Venus Remedies vs Sensex
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-05-04 | Rs.978.75 | - | 35,741.67 | - |
| 2026-05-05 | Rs.947.55 | -3.19% | 35,711.23 | -0.09% |
| 2026-05-06 | Rs.924.50 | -2.43% | 36,211.89 | +1.40% |
| 2026-05-07 | Rs.969.90 | +4.91% | 36,333.79 | +0.34% |
| 2026-05-08 | Rs.1,006.60 | +3.78% | 36,187.29 | -0.40% |
Key Takeaways
Positive Signals: Venus Remedies outperformed the Sensex by 1.60% over the week, closing at a new high of Rs.1,016.15 intraday on 8 May. The stock’s technical indicators are bullish, trading above all major moving averages, and the Mojo Score of 74.0 with a Buy grade supports a positive medium-term outlook. The strong rebound after the lower circuit hit and the upper circuit on the final day demonstrate robust investor interest and momentum.
Cautionary Signals: The lower circuit hit on 6 May reflected significant selling pressure and waning investor participation, with delivery volumes declining sharply. The upper circuit on 8 May was accompanied by reduced delivery volumes, suggesting speculative buying rather than sustained institutional accumulation. The micro-cap status of Venus Remedies implies higher volatility and susceptibility to sharp price swings, warranting careful monitoring of volume and price action in coming sessions.
Conclusion
Venus Remedies Ltd experienced a volatile but ultimately positive week, gaining 2.85% and outperforming the Sensex’s 1.25% rise. The week was defined by a dramatic lower circuit hit midweek, followed by a strong recovery culminating in an upper circuit on the final trading day. These events underscore the stock’s susceptibility to sharp swings driven by supply-demand imbalances and speculative flows typical of micro-cap stocks. While technical indicators and the Mojo Buy rating suggest underlying strength, the contrasting delivery volume trends highlight the need for investor vigilance. Monitoring upcoming trading sessions for sustained volume support and price stability will be crucial to assess the durability of this momentum.
Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →
